Adherence to Treatment with Selective Serotonin Reuptake Inhibitors and the Risk for Fractures and Bone Loss: A Population-Based Cohort Study

CNS Drugs, 06/07/2012

Exposure to Selective serotonin reuptake inhibitor (SSRI) treatment is associated with an increased risk of bone loss–related events.

Print Article Summary Cat 2 CME Report